European Medicines Agency Human Scientific Committees' Working Party with Patients' and Consumers' Organisations meeting with all eligible organisations

  • Email
  • Help

Details

TitleEuropean Medicines Agency Human Scientific Committees' Working Party with Patients' and Consumers' Organisations meeting with all eligible organisations
Date30/11/2012 - 30/11/2012
LocationEuropean Medicines Agency, London, UK
SummaryThis meeting discusses issues in relation to the general involvement of patients' organisations in the Agency’s activities, giving particular focus to the new policy on conflicts of interests, funding of organisations, training strategy, involvement in benefit-risk evaluations and the new pharmacovigilance legislation, as well as presentations concerning the Innovative Medicines Initiative and the European Patients' Academy on Therapeutic Innovation.

All documents

Name Language First published Last updated
Agenda - European Medicines Agency Human Scientific Committees' Working Party with Patients' and Consumers' Organisations meeting with all eligible organisations (English only) 2012-11-23 2013-02-12
List of participants - European Medicines Agency Human Scientific Committees' Working Party with Patients' and Consumers' Organisations plenary meeting with all eligible organisations: 30 November 2012 meeting (English only) 2013-02-12  
Minutes of European Medicines Agency Human Scientific Committees’ Working Party with Patients’ and Consumers’ Organisations meeting with all eligible organisations: 30 November 2012 meeting (English only) 2013-02-12  
Experience following implementation of revised policy on handling of conflicts of interests - Guidance on completion of electronic declaration of interests (S. Kennedy) (English only) 2013-02-12  
Handling conflicts of interest for patients’ and consumers’ organisations (J. Garcia) (English only) 2013-02-12  
European Medicines Agency training strategy for patients and consumers (N. Bere) (English only) 2013-02-12  
Involvement of patients in CHMP benefit-risk (J. Garcia) (English only) 2013-02-12  
Involvement of patients in PRAC benefit-risk (J. M. Raine) (English only) 2013-02-12  
Boosting drug development through public-private partnerships: The Innovative Medicines Initiative model (H. Laverty) (English only) 2013-02-12  
European Patients’ Academy on Therapeutic Innovation (J. Geissler) (English only) 2013-02-12  

Media Videos